AGP Executive Report
Last update: 8 hours agoVaccine Trial: The CDC has moved to set aside $1.6 million for a hepatitis B vaccine trial in Guinea-Bissau that was previously suspended amid international ethics concerns. The proposed funding comes from global health security funds, as questions remain about the study’s revised protocol. Digital Identity: Guinea-Bissau is among seven ECOWAS countries that have launched the bloc’s biometric identity card. ECOWAS is aiming for mutual acceptance at regional borders by December 2026 to ease identity checks and travel. Instant Payments: Guinea-Bissau is included in a new BCEAO list of providers cleared to join the West African Economic and Monetary Union’s interoperable payment system, which aims to enable instant transfers between different banks and financial services.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.